Jon Amund Kyte – Head, Department of Experimental Cancer…
Photo: Sofia Linden / Oslo Cancer Cluster Oncologist Jon Amund Kyte shares some of the groundbreaking immunotherapy research that he and his team is…
Tagged with Cancer
Norway: Staking a Claim as a Pharma Research Hub
Norway, more well-known internationally as an innovation hub for oil & gas and marine biology, is attempting to reverse the trend of reducing…
Ole Alexander Opdalshei – Assistant Secretary General,…
Ole Alexander Opdalshei introduces the role of the Norwegian Cancer Society within Norwegian cancer research, care services and information…
Ketil Widerberg – General Manager, Oslo Cancer Cluster,…
Ketil Widerberg of the Oslo Cancer Cluster highlights how Norway’s excellence in electronic health records can help the country stake out a position…
Cancer in the USA: A Snapshot
In recent years the US has seen an overall decease in cancer deaths thanks to innovative medicines and treatments. However, much work remains to be…
Reclaiming Asia’s Genomic Destiny
The completion of the Human Genome Project (HGP) in April 2003 with the publication of the first human genome sequence is probably one of the most…
MSD SVP Deepak Khanna: Taking a Europe-Wide Approach in the Fight…
There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the EU each year and cancer is set to become the region’s leading cause…
Mexican Pharma Roundup: February 2020
Below is a selection of top recent news from Mexican pharma and healthcare, including the healthcare reforms president Andres Manuel Lopez Obrador is…
Deepak Khanna – SVP & Regional President Oncology…
Speaking at the 2020 European Cancer Forum in Brussels, MSD’s Deepak Khanna outlines the progress that the company is making at the forefront of…
European Cancer Forum 2020: Belgian MoH Maggie De Block Delivers…
The second edition of the European Cancer Forum was held in Brussels, Belgium on Tuesday, 29 January 2020. Hosted by MSD in collaboration with the…
Hot Topics in Chinese Biotech
PharmaBoardroom sat down with more than 25 biotech CEOs in China in 2019. We analyzed the contents of the interviews and found the following recurring…
Sweden’s Excellence in Cancer Care: Behind the Figures
Key stakeholders in Swedish pharma explain why Sweden’s record on cancer care is the best in Europe and what more still needs to be done.…
